Furthermore, in case of advanced/higher grade tumors (C+D = 48), KRAS gene mutations was found 15 (31.25%) and SMAD4 gene was found to be mutated in 14 (29.2%) tumors.
EGFR mutational status is presented in Table 2. None of the reported EGFR mutations was found in matched-normal tissues suggesting their somatic origin and eliminating the possibility to be single-nucleotide polymorphisms.
A variable, however, increase of mutations was found in the cell lines expressing CYP activity.
Only one double mutant, with I117V and E119A mutations, was found in the same subtype.
Overall, the non-synonymous to synonymous ratio of the MAGE mutations was found to be 2.45∶1.
In the four clones chosen from p1, a homogenous S gene with both Q523-L and I769-V (FLv3) mutations was found (Table 1).
A statistically significant difference in the number of non-conservative mutations was found among groups in β-strand A (p<0.03) and β-strand F (p<0.1).
No germline or mosaic mutation for any of the tested EGFR mutations was found in "gene pool" analysis with MAP (Fig. S4).
Additionally, no germline or mosaic mutation for any of the tested EGFR mutations was found in "gene pool" analysis with MAP.
One of these favourable mutations was found to provide all B variant specimens with a Cys residue, which is conserved among the remaining C. trachomatis genotypes and thus may play an important role in maintaining the membrane structural integrity.
In our study, a significantly higher prevalence of NVP-R mutations was found by standard population sequencing among infants receiving SWEN (92%) and diagnosed with HIV infection by six weeks of age than those receiving only SD-NVP (38%).
